Breaking News Instant updates and real-time market news.

2021-03-05 11:25:02 11:25 03/05/21 03/05 11:25 03/05/21 11:25	FX Action: USD-JPY FX Action: USD-JPY pulled back some from the nine-month high of 108.65 seen immediately following the U.S. jobs report, since bottoming at 108.10. Yield differentials continue to support the pairing, with 10-year U.S. rates up in excess of 60 basis points on the year, versus just about 10 basis points for the 10-year JGB. The BoJ continues to keep the yield curve under control, which in the current environment of rising rates, has weighed heavily on the Yen. The 200-week moving average at 109.04 is the next major resistance level.

2021-03-05 11:25:02

11:25

03/05/21

03/05

11:25

03/05/21

11:25

FX Action: USD-JPY

FX Action: USD-JPY pulled back some from the nine-month high of 108.65 seen immediately following the U.S. jobs report, since bottoming at 108.10. Yield differentials continue to support the pairing, with 10-year U.S. rates up in excess of 60 basis points on the year, versus just about 10 basis points for the 10-year JGB. The BoJ continues to keep the yield curve under control, which in the current environment of rising rates, has weighed heavily on the Yen. The 200-week moving average at 109.04 is the next major resistance level.

TODAY'S FREE FLY STORIES

General news	FX Action: USD-CAD » 08:50 04/12/21 04/12 08:50 04/12/21 08:50 $ECON Economic Data / + FX Action: USD-CAD eased… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Hot Stocks	Vertex Pharmaceuticals appoints Yvette Burton as chief people innovation officer » 08:49 04/12/21 04/12 08:49 04/12/21 08:49 VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) Vertex is honored to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 03/26/21 Vertex Pharmaceuticals receives CHMP recommendation for Kaftrio label extension 03/24/21 Vertex receives Australian G approval for TRIKAFTA 03/10/21 Vertex gets FDA fast track designation for VX-880 03/07/21 Fly Intel: Top five weekend stock stories VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 03/25/21 Citi Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List 02/23/21 Baird Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts 02/23/21 Baird Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird 02/02/21 Credit Suisse Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 02/01/21 Vertex Pharmaceuticals reports Q4 EPS $2.51, consensus $2.59 02/01/21 Notable companies reporting after market close 10/29/20 Vertex Pharmaceuticals reports Q3 EPS $2.64, consensus $2.34 10/29/20 Notable companies reporting after market close VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 03/06/21 Vertex underperformance after drug setback a buying opportunity, Barron's says 02/02/21 Amicus, BioMarin speculated by Dealreporter as possible Vertex targets 10/16/20 Amicus 'a name to watch' if Vertex seeks M&A, Dealreporter says VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 02/01/21 Fly Intel: After-Hours Movers 12/07/20 Crispr rises following ASH update for genome editing cell therapy candidate 10/15/20 Fly Intel: Wall Street's top stories for Thursday 10/15/20 Fly Intel: Wall Street's top stories at midday 06/08/21 PDUFA Date for TRIKAFTA 05/19/21 Vertex Pharmaceuticals Incorporated VRTX Vertex Pharmaceuticals $213.43 / +3.01 (+1.43%) 02/01/21 Vertex options imply 7.0% move in share price post-earnings 11/12/20 Early notable gainers among liquid option names on November 12th 10/28/20 Vertex call volume above normal and directionally bullish 10/16/20 Early notable gainers among liquid option names on October 16th
Hot Stocks	Sanofi to invest EUR 400M in vaccine production site in Singapore » 08:49 04/12/21 04/12 08:49 04/12/21 08:49 SNY Sanofi $50.80 / +0.43 (+0.85%) Sanofi announced a plan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SNY Sanofi $50.80 / +0.43 (+0.85%) 08:06 Today Jounce Therapeutics appoints Dmitri Wiederschain as Chief Scientific Officer 07:21 Today C4XD enters licensing agreement with Sanofi for oral IL-17A inhibitor program 04/09/21 Sanofi acquires Tidal Therapeutics for $160M upfront payment 04/09/21 Sanofi says interim late-breaking data validate not-alpha profile of THOR-707 SNY Sanofi $50.80 / +0.43 (+0.85%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day SNY Sanofi $50.80 / +0.43 (+0.85%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year SNY Sanofi $50.80 / +0.43 (+0.85%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports SNY Sanofi $50.80 / +0.43 (+0.85%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 04/28/21 Sanofi - SNY 05/18/21 PDUFA Date for Avalglucosidase Alfa
Conference/Events	GMS Inc. management to meet virtually with Truist » 08:49 04/12/21 04/12 08:49 04/12/21 08:49 GMS GMS Inc. $42.34 / +0.63 (+1.51%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GMS GMS Inc. $42.34 / +0.63 (+1.51%) 02/03/21 GMS Inc. announces acquisition of D.L. Building Materials 11/17/20 GMS Inc. falls -9.2% GMS GMS Inc. $42.34 / +0.63 (+1.51%) 03/05/21 Truist GMS price target raised to $42 from $34 at Truist 03/05/21 Barclays GMS Inc. price target raised to $37 from $35 at Barclays 12/04/20 Fly Intel: Top five analyst downgrades 12/04/20 Stephens Stephens downgrades GMS Inc. to Equal Weight, sees few near-term catalysts GMS GMS Inc. $42.34 / +0.63 (+1.51%) 03/04/21 GMS Inc. reports Q3 adjusted EPS 60c, consensus 51c 12/03/20 GMS Inc. reports Q2 adjusted EPS 93c, consensus 91c 04/13/21 GMS Inc.
Hot Stocks	Riot Blockchain produces 187 bitcoin in March » 08:48 04/12/21 04/12 08:48 04/12/21 08:48 RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) Riot Blockchain announces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) 04/08/21 Riot Blockchain to acquire Whinstone for in a transaction valued at $651M 04/08/21 Riot Blockchain to acquire Whinstone for $80M cash, 11.8M shares of stock 04/07/21 Riot Blockchain announces purchase order of 42,000 S19j Antminers 04/06/21 Riot Blockchain appoints Megan Brooks as COO RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) 11/23/20 H.C. Wainwright Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) 03/31/21 Riot Blockchain reports Q4 net income $3.9M vs. ($3.4M) last year RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) 04/09/21 The Intersection: Crypto and Wall Street This Week 03/26/21 The Intersection: Crypto and Wall Street This Week 03/19/21 The Intersection: Crypto and Wall Street This Week 03/12/21 The Intersection: Crypto and Wall Street This Week RIOT Riot Blockchain $49.64 / +0.17 (+0.34%) 04/08/21 Riot Blockchain call volume above normal and directionally bullish 03/30/21 Riot Blockchain options imply 10.7% move in share price post-earnings 03/29/21 Riot Blockchain options imply 14.0% move in share price post-earnings 03/24/21 Riot Blockchain call volume above normal and directionally bullish

Downgrade	Vaalco Energy downgraded to Neutral from Buy at Roth Capital » 08:47 04/12/21 04/12 08:47 04/12/21 08:47 EGY Vaalco Energy $2.25 / -0.015 (-0.66%) Roth Capital analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EGY Vaalco Energy $2.25 / -0.015 (-0.66%) 05:14 Today Vaalco Energy CEO Cary Bounds to leave, George Maxwell to succeed 03/18/21 Vaalco Energy CFO Elizabeth Prochnow to retire 11/17/20 Vaalco Energy to acquire Sasol Gabon interest in Etame Marine block EGY Vaalco Energy $2.25 / -0.015 (-0.66%) 03/24/21 Roth Capital Vaalco Energy initiated with a Buy at Roth Capital
Periodicals	General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports » 08:46 04/12/21 04/12 08:46 04/12/21 08:46 GM General Motors $60.15 / +0.08 (+0.13%) General Motors'… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GM General Motors $60.15 / +0.08 (+0.13%) 04/06/21 GM says Chevrolet will introduce Silverado electric pickup truck 04/05/21 GM to reveal plans for additional EV production at Factory ZERO plant 04/01/21 GM targets recovering lost production where possible in second half 04/01/21 General Motors reports U.S. Q1 sales up 4% to 642,250 vehicles GM General Motors $60.15 / +0.08 (+0.13%) 04/05/21 Fly Intel: Top five analyst initiations 04/05/21 Wells Fargo General Motors initiated with an Overweight at Wells Fargo 03/29/21 Jefferies General Motors price target raised to $62 from $50 at Jefferies 03/24/21 Morgan Stanley American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley GM General Motors $60.15 / +0.08 (+0.13%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $60.15 / +0.08 (+0.13%) 04/09/21 GM to cut overtime production at two U.S. truck plants this weekend, CNBC says 04/08/21 GM to pause output at several North American plants amid chip shortage, WSJ says 04/08/21 GM to resume midsize truck production, halt other production, Detroit News says 04/07/21 White House proposal calls for $100B in new EV consumer rebates, Reuters says GM General Motors $60.15 / +0.08 (+0.13%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street GM General Motors $60.15 / +0.08 (+0.13%) 04/07/21 Notable open interest changes for April 7th 03/24/21 General Motors call volume above normal and directionally bullish 03/03/21 Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish
Recommendations	Qualtrics price target lowered to $38 from $45 at BMO Capital » 08:45 04/12/21 04/12 08:45 04/12/21 08:45 XM Qualtrics $32.09 / -0.52 (-1.59%) BMO Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XM Qualtrics $32.09 / -0.52 (-1.59%) 04/08/21 Qualtrics announces new partnership with IBM Japan 04/06/21 Qualtrics and ServiceNow announce strategic partnership 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/29/21 Robinhood updates limit on GameStop buys to one share, restricts other positions XM Qualtrics $32.09 / -0.52 (-1.59%) 04/09/21 Barclays Qualtrics price target lowered to $35 from $39 at Barclays 03/17/21 Fly Intel: Top five analyst initiations 03/17/21 HSBC Qualtrics initiated with a Hold at HSBC 03/17/21 HSBC Qualtrics initiated with a Hold at HSBC XM Qualtrics $32.09 / -0.52 (-1.59%) 03/09/21 Notable companies reporting after market close 28 Jan XM Qualtrics $32.09 / -0.52 (-1.59%) 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports XM Qualtrics $32.09 / -0.52 (-1.59%) 03/10/21 Fly Intel: Pre-market Movers 02/24/21 Square, Workhorse downgrades among today's top calls on Wall Street 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut 01/24/21 Opening Day: Mytheresa raises $407M in U.S. market debut 04/21/21 Qualtrics - XM 05/19/21 Qualtrics International Inc. XM Qualtrics $32.09 / -0.52 (-1.59%) 02/03/21 new option listings on February 3rd
Hot Stocks	Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:45 04/12/21 04/12 08:45 04/12/21 08:45 CP Canadian Pacific $375.60 / +0.475 (+0.13%) , KSU Kansas City Southern $262.21 / -0.01 (-0.00%) Canadian Pacific Railway… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 08:45 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 08:44 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 08:45 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 08:44 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 04/09/21 Scotiabank Canadian Pacific price target raised to C$516 from C$510 at Scotiabank 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/30/21 National Bank Canadian Pacific upgraded to Outperform from Sector Perform at National Bank KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/26/21 Vertical Research Kansas City Southern reinstated with a Hold at Vertical Research 03/23/21 Cowen Wabtec remains positioned to benefit from rail market, says Cowen CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 01/27/21 Canadian Pacific sees FY21 double-digit adjusted diluted EPS growth 01/27/21 Canadian Pacific reports Q4 adjusted EPS C$5.06 vs. C$4.77 last year 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 01/21/21 Notable companies reporting before tomorrow's open KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers 04/16/21 Kansas City Southern - KSU 04/21/21 Canadian Pacific - CP 05/20/21 Kansas City Southern KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Early notable gainers among liquid option names on March 22nd
Hot Stocks	Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:45 04/12/21 04/12 08:45 04/12/21 08:45 CP Canadian Pacific $375.60 / +0.475 (+0.13%) , KSU Kansas City Southern $262.21 / -0.01 (-0.00%) Canadian Pacific Railway… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 08:44 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 08:44 Today Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 04/09/21 Scotiabank Canadian Pacific price target raised to C$516 from C$510 at Scotiabank 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/30/21 National Bank Canadian Pacific upgraded to Outperform from Sector Perform at National Bank KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/26/21 Vertical Research Kansas City Southern reinstated with a Hold at Vertical Research 03/23/21 Cowen Wabtec remains positioned to benefit from rail market, says Cowen CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 01/27/21 Canadian Pacific sees FY21 double-digit adjusted diluted EPS growth 01/27/21 Canadian Pacific reports Q4 adjusted EPS C$5.06 vs. C$4.77 last year 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 01/21/21 Notable companies reporting before tomorrow's open KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers 04/16/21 Kansas City Southern - KSU 04/21/21 Canadian Pacific - CP 05/20/21 Kansas City Southern KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Early notable gainers among liquid option names on March 22nd

Options	Largest borrow rate increases among liquid names » 08:45 04/12/21 04/12 08:45 04/12/21 08:45 SGLB Sigma Labs $3.75 / -0.04 (-1.06%) , CHPT ChargePoint $27.64 / -0.93 (-3.26%) , BLNK Blink Charging $44.04 / -1.89 (-4.11%) , AYRO AYRO $5.89 / -0.01 (-0.17%) , IGC India Globalization Capital $1.73 / -0.005 (-0.29%) , THCB Tuscan Holdings Corp. $12.61 / +0.21 (+1.69%) , TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) , INVZ Innoviz Technologies $12.08 / +0.25 (+2.11%) , BLDP Ballard Power $23.29 / -0.775 (-3.22%) Latest data shows the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SGLB CHPT BLNK AYRO IGC THCB TRIL BLDP SGLB Sigma Labs $3.75 / -0.04 (-1.06%) 04/07/21 Sigma Labs selected by Ermaksan to provide PrintRite3DB as factory option 03/15/21 Sigma Labs awarded PrintRite3D contract by Lockheed Martin 10/22/20 Sigma Labs announces PrintRite3D for Directed Energy Deposition 10/14/20 Sigma Labs partnered with IN4.OS to build smart factories CHPT ChargePoint $27.64 / -0.93 (-3.26%) 04/01/21 ChargePoint rises 11.3% 04/01/21 ChargePoint rises 9.0% 03/31/21 ChargePoint rises 16.0% 03/30/21 ChargePoint sees 'significant progress' toward collaborative's $1B charging goal BLNK Blink Charging $44.04 / -1.89 (-4.11%) 04/08/21 Blink Charging to deploy 42 charging ports at New York Four Brothers Pizza Inns 04/06/21 Blink Charging sponsor University of Cincinnati's first all-electric racing team 04/01/21 Blink Charging announces charging stations deployed in Chile 03/11/21 Blink Charging awarded grant from Ohio Environmental Protection Agency AYRO AYRO $5.89 / -0.01 (-0.17%) 03/17/21 AYRO enters agreement with Element Fleet Management 03/08/21 AYRO announces launch of Electric Vaccine Vehicle IGC India Globalization Capital $1.73 / -0.005 (-0.29%) 03/31/21 NY Governor Cuomo signs bill to legalize adult-use cannabis 03/29/21 Cuomo, NY leaders announce agreement to legalize adult-use cannabis 03/18/21 PA Gov. Wolf: 'Can finally right the wrongs' with legalized marijuana 03/08/21 India Globalization Capital receives patent for cannabinoid-based cream THCB Tuscan Holdings Corp. $12.61 / +0.21 (+1.69%) 03/31/21 Tuscan Holdings Corp. announces meeting to approve extension amendment 02/05/21 Microvast, Oshkosh enter joint development agreement 02/01/21 Microvast to become public through $3B Tuscan Holdings Corp. merger agreement 02/01/21 Tuscan Holdings Corporation trading resumes TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) 01/12/21 Pfizer invests $120M in four clinical-stage biotech companies 11/16/20 Trillium Therapeutics reports Q3 EPS (58c), consensus (90c) 11/02/20 Trillium Therapeutics appoints Ingmar Bruns M.D as Chief Medical Officer 11/02/20 Trillium Therapeutics announced the formation of a Scientific Advisory Board BLDP Ballard Power $23.29 / -0.775 (-3.22%) 03/31/21 Linamar partners with Roush, Ballard on Fuel Cell Electric Vehicle Delivery Vans 03/16/21 Ballard Power's FCmove fuel cell module to power electric buses in New Zealand 03/10/21 Ballard Power appoints Paul Dobson as CFO 03/09/21 Canadian Pacific to employ Ballard's fuel cell modules SGLB CHPT BLNK AYRO IGC THCB TRIL INVZ BLDP SGLB Sigma Labs $3.75 / -0.04 (-1.06%) CHPT ChargePoint $27.64 / -0.93 (-3.26%) 03/25/21 Citi ChargePoint initiated with a Neutral at Citi 03/08/21 Cowen ChargePoint initiated with an Outperform at Cowen 03/08/21 Cowen ChargePoint initiated with an Outperform at Cowen 03/02/21 Oppenheimer ChargePoint initiated with an Outperform at Oppenheimer BLNK Blink Charging $44.04 / -1.89 (-4.11%) 03/08/21 Cowen Blink Charging initiated with an Outperform at Cowen 02/05/21 Roth Capital Blink Charging initiated with a Buy at Roth Capital 08/14/20 Fly Intel: Top five analyst downgrades 08/14/20 H.C. Wainwright Blink Charging downgraded to Neutral from Buy at H.C. Wainwright AYRO AYRO $5.89 / -0.01 (-0.17%) IGC India Globalization Capital $1.73 / -0.005 (-0.29%) 03/29/21 Stifel Stifel says New York adult use cannabis market represents $5B opportunity 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session THCB Tuscan Holdings Corp. $12.61 / +0.21 (+1.69%) TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) 11/18/20 Craig-Hallum Trillium Therapeutics price target raised to $21 from $15 at Craig-Hallum 11/04/20 Cowen Trillium ASH abstracts provide 'minimal updates', says Cowen 10/12/20 Evercore ISI Trillium Therapeutics initiated with an Outperform at Evercore ISI 10/05/20 Piper Sandler Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler INVZ Innoviz Technologies $12.08 / +0.25 (+2.11%) BLDP Ballard Power $23.29 / -0.775 (-3.22%) 03/30/21 Northcoast Ballard Power initiated with a Neutral at Northcoast 03/12/21 Lake Street Ballard Power price target raised to $35 from $20 at Lake Street 03/12/21 BMO Capital Ballard Power price target lowered to $35 from $38 at BMO Capital 03/12/21 Citi Ballard Power price target lowered to $33 from $42 at Citi CHPT BLNK AYRO TRIL BLDP CHPT ChargePoint $27.64 / -0.93 (-3.26%) 03/11/21 ChargePoint sees Q1 revenue $35M-$40M 03/11/21 ChargePoint reports Q4 EPS ($5.29) vs. ($3.05) last year 03/11/21 Notable companies reporting after market close BLNK Blink Charging $44.04 / -1.89 (-4.11%) 03/25/21 Blink Charging reports Q4 EPS (24c), consensus (12c) 11/12/20 Blink Charging reports Q3 EPS (12c), two estimates (9c) AYRO AYRO $5.89 / -0.01 (-0.17%) 03/31/21 AYRO reports 2020 EPS (73c) vs. ($2.95) last year 11/06/20 AYRO reports Q3 EPS (13c) vs. (77c) last year TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) 11/16/20 Trillium Therapeutics reports 9M EPS ($2.19) vs. (93c) last year BLDP Ballard Power $23.29 / -0.775 (-3.22%) 03/10/21 Ballard Power reports Q4 EPS (5c), consensus (4c) 03/09/21 Ballard Power announces follow-on purchase orders from Wrightbus 01/12/21 Ballard Power awarded order from Arcola Energy for FCmoveTM-HD fuel cell modules 11/06/20 Ballard Power reports Q3 EPS (5c), consensus (5c) 10 Mar 10 Feb 08 Jan 08 Jan 24 Nov 11 Sep BLNK IGC BLNK Blink Charging $44.04 / -1.89 (-4.11%) 11/23/20 Citron attacks Blink Charging, says shares heading back to $10 11/23/20 Citron calls Blink Charging 'most ridiculous' electric vehicle stock 11/23/20 Blink Charging should trade back to $10, Citron Research says IGC India Globalization Capital $1.73 / -0.005 (-0.29%) 03/24/21 Deal reached on bill legalizing marijuana in NY, Spectrum News NY1 says 03/17/21 Marijuana banking bill to be reintroduced, Marijuana Moment's Angell says 03/15/21 NY Governor Cuomo says state 'very close' to legalizing marijuana, RF says 03/11/21 Peoples-Stokes sees marijuana legalization deal soon, Buffalo News reports CHPT BLNK AYRO IGC THCB TRIL CHPT ChargePoint $27.64 / -0.93 (-3.26%) 03/29/21 Charged: Tesla accepting bitcoin as form of payment for cars 03/11/21 Fly Intel: After-Hours Movers 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal BLNK Blink Charging $44.04 / -1.89 (-4.11%) 03/25/21 Fly Intel: After-Hours Movers 03/13/21 Charged: Tesla seen losing share to Ford in U.S., Volkswagen in Europe 03/11/21 Fly Intel: Wall Street's top stories at midday 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal AYRO AYRO $5.89 / -0.01 (-0.17%) 02/11/21 Fly Intel: Wall Street's top stories at midday IGC India Globalization Capital $1.73 / -0.005 (-0.29%) 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal 04/01/21 Rising High: An exclusive talk with cannabinoid market research firm BDSA 03/25/21 Rising High: An exclusive talk with medical cannabis digital network SheCann 03/18/21 Rising High: An exclusive talk with cannabis retailer Fire & Flower THCB Tuscan Holdings Corp. $12.61 / +0.21 (+1.69%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 02/01/21 Fly Intel: Pre-market Movers TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) 03/18/21 Fly Intel: After-Hours Movers 06/22/21 2021 Energy, Power & Renewables Virtual Conference 05/04/21 Ballard Power - BLDP SGLB CHPT BLNK AYRO IGC THCB TRIL INVZ BLDP SGLB Sigma Labs $3.75 / -0.04 (-1.06%) 03/24/21 Sigma Labs options imply 17.9% move in share price post-earnings 03/17/21 Largest borrow rate increases among liquid names 02/18/21 Fourteen new option listings and one option delisting on February 18th CHPT ChargePoint $27.64 / -0.93 (-3.26%) 04/06/21 ChargePoint Holdings call volume above normal and directionally bullish 04/01/21 Unusually active option classes on open April 1st 04/01/21 Largest borrow rate increases among liquid names 03/31/21 ChargePoint Holdings call volume above normal and directionally bullish BLNK Blink Charging $44.04 / -1.89 (-4.11%) 04/08/21 Largest borrow rate increases among liquid names 04/01/21 Unusually active option classes on open April 1st 03/31/21 Unusually active option classes on open March 31st 03/25/21 Blink Charging options imply 15.7% move in share price post-earnings AYRO AYRO $5.89 / -0.01 (-0.17%) 02/05/21 Largest borrow rate increases among liquid names 12/30/20 Largest borrow rate increases among liquid names 12/21/20 Largest borrow rate increases among liquid names 11/30/20 Largest borrow rate increases among liquid names IGC India Globalization Capital $1.73 / -0.005 (-0.29%) 03/26/21 Largest borrow rate increases among liquid names 03/17/21 Largest borrow rate increases among liquid names 03/10/21 Largest borrow rate increases among liquid names 02/17/21 Largest borrow rate increases among liquid names THCB Tuscan Holdings Corp. $12.61 / +0.21 (+1.69%) 02/08/21 Three new option listings and two option delistings on February 8th TRIL Trillium Therapeutics $10.45 / -0.73 (-6.53%) 11/16/20 Largest borrow rate increases among liquid names INVZ Innoviz Technologies $12.08 / +0.25 (+2.11%) 04/06/21 One new option listing and three option delistings on April 6th BLDP Ballard Power $23.29 / -0.775 (-3.22%) 02/26/21 Largest borrow rate increases among liquid names 02/08/21 Largest borrow rate increases among liquid names 12/08/20 Ballard Power call volume above normal and directionally bullish
Hot Stocks	Canadian Pacific, Kansas City Southern get backers for U.S.-Mexico-Canada rail » 08:44 04/12/21 04/12 08:44 04/12/21 08:44 CP Canadian Pacific $375.60 / +0.475 (+0.13%) , KSU Kansas City Southern $262.21 / -0.01 (-0.00%) Canadian Pacific Railway… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports 03/24/21 North American rail traffic rose 9.5% in week ended March 20, AAR reports KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 04/07/21 North American rail traffic rose 17.6% in week ended April 3 04/06/21 Canadian Pacific and Kansas City Southern receive support for network project 03/31/21 North American rail traffic rose 14.1% in week ended March 27, AAR reports 03/24/21 North American rail traffic rose 9.5% in week ended March 20, AAR reports CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 04/09/21 Scotiabank Canadian Pacific price target raised to C$516 from C$510 at Scotiabank 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/30/21 National Bank Canadian Pacific upgraded to Outperform from Sector Perform at National Bank KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 04/06/21 Susquehanna Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna 03/31/21 National Bank National Bank upgrades Canadian Pacific on likelihood of deal approval 03/26/21 Vertical Research Kansas City Southern reinstated with a Hold at Vertical Research 03/23/21 Cowen Wabtec remains positioned to benefit from rail market, says Cowen CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 01/27/21 Canadian Pacific sees FY21 double-digit adjusted diluted EPS growth 01/27/21 Canadian Pacific reports Q4 adjusted EPS C$5.06 vs. C$4.77 last year 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 01/21/21 Notable companies reporting before tomorrow's open KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports CP KSU CP Canadian Pacific $375.60 / +0.475 (+0.13%) 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers 04/16/21 Kansas City Southern - KSU 04/21/21 Canadian Pacific - CP 05/20/21 Kansas City Southern KSU KSU Kansas City Southern $262.21 / -0.01 (-0.00%) 03/22/21 Early notable gainers among liquid option names on March 22nd
Hot Stocks	Roche confirms REGN-COV 2069 trial met primary and key secondary endpoints » 08:43 04/12/21 04/12 08:43 04/12/21 08:43 RHHBY Roche $41.93 / +0.53 (+1.28%) , REGN Regeneron $475.52 / -0.61 (-0.13%) Roche (RHHBY) confirmed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 07:05 Today IGM Biosciences appoints George Gauthier as chief commercial officer 04/05/21 Prothena appoints Hideki Garren as chief medical officer 04/01/21 PTC Therapeutics to receive $20M commercial milestone payment from Roche 03/30/21 Roche announces European Commission approval of Evrysdi REGN Regeneron $475.52 / -0.61 (-0.13%) 05:28 Today Regeneron announces second REGEN-COV trial meets primary endpoint 05:24 Today Regeneron announces REGEN-COV trial meets primary, secondary endpoints 04/09/21 Regeneron: NIH COVID-19 guidelines strongly recommend use of REGEN-COV 04/01/21 FDA approves Praluent as on add-on therapy for adult patients with HoFH RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 08:33 Today B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback REGN Regeneron $475.52 / -0.61 (-0.13%) 03/24/21 Canaccord Regeneron trial shows positive results against COVID-variants, says Canaccord 03/23/21 Piper Sandler Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler 03/11/21 Evercore ISI Kodiak Sciences initiated with an Outperform at Evercore ISI 03/11/21 Needham Vir Biotechnology price target raised to $80 from $75 at Needham RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year REGN Regeneron $475.52 / -0.61 (-0.13%) 02/05/21 Regeneron reports Q4 EPS $9.53, consensus $8.39 02/04/21 Notable companies reporting before tomorrow's open 02/04/21 Notable companies reporting before tomorrow's open 11/05/20 Regeneron reports Q3 EPS $8.36, consensus $7.13 27 May RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says REGN Regeneron $475.52 / -0.61 (-0.13%) 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/04/20 Regeneron must face DOJ suit citing kickbacks, Bloomberg says 11/17/20 Regeneron says Roche completed early tests to make COVID drug, Reuters says RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback 03/23/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Fly Intel: Pre-market Movers REGN Regeneron $475.52 / -0.61 (-0.13%) 02/05/21 Fly Intel: Pre-market Movers 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Regeneron - REGN 10/21/21 PDUFA Date for Dupixent (Dupilumab) 06/11/21 Regeneron Pharmaceuticals REGN REGN Regeneron $475.52 / -0.61 (-0.13%) 01/13/21 Early notable gainers among liquid option names on January 13th 12/18/20 Early notable gainers among liquid option names on December 18th 11/06/20 Regeneron put volume heavy and directionally bearish
Hot Stocks	GTEC Holdings repays $6M loan, eliminates all debt » 08:41 04/12/21 04/12 08:41 04/12/21 08:41 GGTTF GTEC Holdings / + GTEC is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News GGTTF GTEC Holdings / + 03/01/21 GTEC Holdings repays convertible debt in full
Hot Stocks	Popular raises dividend to 45c per share, announces $350M stock repurchase plan » 08:40 04/12/21 04/12 08:40 04/12/21 08:40 BPOP Popular $71.50 / +0.27 (+0.38%) Popular announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BPOP Popular $71.50 / +0.27 (+0.38%) 02/24/21 Popular VP Gilberto Monzon sells over $325K in shares 10/28/20 Popular implements branch realignment in New York metro region BPOP Popular $71.50 / +0.27 (+0.38%) 01/29/21 RBC Capital Popular price target raised to $70 from $48 at RBC Capital 01/08/21 UBS Popular upgraded to Buy from Neutral at UBS 09/22/20 Top five analyst initiations 09/22/20 UBS Popular initiated with a Neutral at UBS BPOP Popular $71.50 / +0.27 (+0.38%) 01/28/21 Popular reports Q4 EPS $2.10, consensus $1.54 10/28/20 Popular reports Q3 EPS $2.00, consensus $1.20 04/28/21 Popular - BPOP

Hot Stocks	Lottery.com signs engagement letter with Ritzio International » 08:39 04/12/21 04/12 08:39 04/12/21 08:39 TDAC Trident Acquisitions Corp. $13.27 / +0.345 (+2.67%) Lottery.com has signed an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News TDAC Trident Acquisitions Corp. $13.27 / +0.345 (+2.67%) 04/05/21 Lottery.com acquires domain Sports.com 04/01/21 Lottery.com appoints Katie Lever as CLO 03/29/21 Lottery.com enters agreement with Payday Lotteries, offer products in Nigeria 03/22/21 Lottery.com to acquire JeugaLotto, Aganar, terms not disclosed
Earnings	CACI Names Glenn Kurowski CTO » 08:39 04/12/21 04/12 08:39 04/12/21 08:39 CACI CACI $251.61 / +2.4 (+0.96%) CACI International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CACI CACI $251.61 / +2.4 (+0.96%) 04/08/21 CACI gets $700M BPA from the U.S. Department of Homeland Security 04/01/21 CACI awarded $372.85M USSOCOM contract 03/12/21 CACI announces $500M accelerated share repurchase program 03/11/21 CACI announces $500M accelerated share repurchase program CACI CACI $251.61 / +2.4 (+0.96%) 03/26/21 Stifel Stifel downgrades SAIC to Hold after 'materially reset' expectations 02/23/21 William Blair William Blair reiterates Outperform on Leidos following quarterly results 01/29/21 Truist CACI price target raised to $290 from $275 at Truist 01/27/21 Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel CACI CACI $251.61 / +2.4 (+0.96%) 01/27/21 CACI sees FY21 EPS $14.47-$15.25, consensus $15.01 01/27/21 CACI reports Q2 EPS $4.18, consensus $3.60 10/28/20 CACI raises FY21 EPS view to $14.47-$15.25 from $13.50-$14.28 10/28/20 CACI reports Q1 EPS $3.67, consensus $3.11 04/22/21 CACI - CACI
Hot Stocks	Allogene, Springworks announce first patient dosed in Phase 1 study of ALLO-715 » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) , SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) Allogene Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 04/11/21 Allogene presents preclinical data expanding utility of TurboCAR platform 12/23/20 Allogene receives IND clearance from FDA for ALLO-715, nirogacestat combination 12/15/20 Allogene Therapeutics, Overland Pharmaceuticals form joint venture in China 12/07/20 Allogene Therapeutics presents preclinical findings on ALLO-605 SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 04/01/21 SpringsWorks Therapeutics doses first patient in Phase 1b nirogacestat study 03/22/21 SpringsWorks Therapeutics names Bhavesh Ashar as Chief Commercial Officer 02/25/21 SpringsWorks reports results from Phase 2b ReNeu trial of mirdametinib 12/15/20 SpringsWorks Therapeutics promotes Badreddin Edris to COO ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 03/01/21 H.C. Wainwright Allogene Therapeutics price target raised to $43 from $40 at H.C. Wainwright 01/26/21 Stifel Allogene Therapeutics upgraded to Buy from Hold at Stifel 12/28/20 H.C. Wainwright SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright 12/10/20 H.C. Wainwright Allogene Therapeutics assumed with a Buy at H.C. Wainwright SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 03/30/21 JPMorgan SpringsWorks Therapeutics added to Analyst Focus List at JPMorgan 02/26/21 Barclays SpringsWorks Therapeutics price target raised to $105 from $92 at Barclays 02/25/21 H.C. Wainwright SpringsWorks price target raised to $124 from $101 at H.C. Wainwright 01/22/21 Barclays SpringsWorks Therapeutics price target raised to $92 from $83 at Barclays ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 11/04/20 Allogene Therapeutics reports Q3 EPS (52c), consensus (54c) SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 02/25/21 SpringsWorks Therapeutics reports Q4 EPS 24c, consensus (10c) 11/12/20 SpringsWorks Therapeutics reports Q3 EPS (51c), consensus (48c) 02 Mar 08 Oct 02 Jun ALLO ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 11/04/20 Fly Intel: Wall Street's top stories for Wednesday 11/04/20 Fly Intel: Wall Street's top stories at midday SWTX SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 04/08/21 Five new option listings and one option delisting on April 8th
General news	Fed Chair Powell reiterated the FOMC will continue to support the recovery » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 $ECON Economic Data / + Fed Chair Powell… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Downgrade	Argo Group downgraded to Neutral from Outperform at Boenning & Scattergood » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 ARGO Argo Group $54.05 / -0.13 (-0.24%) Boenning &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ARGO Argo Group $54.05 / -0.13 (-0.24%) 02/17/21 Argo Group reports Q4 combined ratio 110.0% vs. 126.7% last year 02/08/21 Argo Group names Scott Kirk as new CFO effective March 1st 02/02/21 Argo Group estimates Q4 catastrophe losses at $38M 12/23/20 Argo Group announces sale of Italian business, terms not disclosed ARGO Argo Group $54.05 / -0.13 (-0.24%) 03/15/21 HSBC Argo Group price target raised to $10.25 from $7 at HSBC 03/15/21 Compass Point Argo Group upgraded to Buy from Neutral at Compass Point 01/06/21 Compass Point Argo Group price target raised to $47 from $41 at Compass Point 11/11/20 Compass Point Argo Group downgraded to Neutral after vaccine-fueled rally at Compass Point ARGO Argo Group $54.05 / -0.13 (-0.24%) 02/17/21 Argo Group reports Q4 EPS (57c), consensus (39c) 11/02/20 Argo Group reports Q3 EPS (91c), consensus (62c) 05/04/21 Argo Group - ARGO

Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Talend: 'Go-shop' period expires related to Thoma Bravo acquistion » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 TLND Talend $64.71 / +0.27 (+0.42%) Talend announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TLND Talend $64.71 / +0.27 (+0.42%) 04/01/21 Talend and Thomas Bravo announce expiration of HSR period for tender offer 03/10/21 Talend trading resumes 03/10/21 Talend to resume trading at 9:00am ET 03/10/21 Talend to be acquired by Thoma Bravo at $66 per share in $2.4B cash deal TLND Talend $64.71 / +0.27 (+0.42%) 03/11/21 Fly Intel: Top five analyst downgrades 03/11/21 Needham Talend downgraded to Hold from Buy at Needham 03/10/21 Craig-Hallum Talend go-shop 'could spark interest,' says Craig-Hallum 03/10/21 William Blair Talend downgraded to Market Perform from Outperform at William Blair TLND Talend $64.71 / +0.27 (+0.42%) 02/10/21 Talend guides initial FY21 EPS (89c) to (83c), consensus (75c) 02/10/21 Talend sees Q1 EPS (27c) to (24c), consensus (21c) 02/10/21 Talend reports Q4 EPS (10c), consensus (30c) TLND Talend $64.71 / +0.27 (+0.42%) 03/10/21 Fly Intel: Wall Street's top stories for Wednesday 03/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: After-Hours Movers 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials 12/22/20 Genprex completes manufacturing scale-up for Reqorsa production GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners

Events

Earnings calls, analyst events, roadshows and more

APHA
Today at 09:00

Aphria - APHA Conference Calls
Today at 09:00

Infrastructure Industry Meetings
BBVA
Today at 09:00

European Banking/Financials Industry Meetings
ZLAB
Today at 10:00

Zai Lab - ZLAB Conference Calls
OTCM
Today at 10:00

OTC Markets Group Inc. Firm Sponsored Meetings

Virtual Meeting
Today at 10:00

Energy Industry Meetings
Today at 10:00

Retail/Softlines & Dept Stores Industry Meetings
CRDF
Today at 11:00

Cardiff Oncology - CRDF Conference Calls
GNL
Today at 11:00

Global Net Lease, Inc. Firm Sponsored Meetings
RXT
Today at 11:00

Rackspace Technology Firm Sponsored Meetings

Virtual Roundtable

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

FX Action: USD-JPY

TODAY'S FREE FLY STORIES

Get Full Fly Access